Ocampo Christine, who is Vice President, Finance at AVANIR Pharmaceuticals, sold 55,000 shares at $9.45 on Sept. 17, 2014. Following this transaction, the Vice President, Finance owned 79,871 shares meaning that the stake was reduced by 40.78% with the 55,000-share transaction.
Palekar Rohan, who is SVP & Chief Commercial Officer at AVANIR Pharmaceuticals, sold 25,000 shares at $11.50 on Sept. 17, 2014. Following this transaction, the SVP & Chief Commercial Officer owned 266,750 shares meaning that the stake was reduced by 8.57% with the 25,000-share transaction.
I saw someone said
"gld shares have not been been available to lend at most houses,this is the first time this has happened since inception.The gold market has been pure hell for 5 years. It is time for the BLAST OFF!IF ANY KIND OF BUYING COMES INTO THE JUNIORS THEY WILL EXPLODE"
Today the Chinese government backed Shanghai Gold Exchange (SGE) brought forward the launch date of its international gold trading platform which is hosted in the city’s free trade zone (FTZ). The gold trading platform will be known as the ‘international board.’
In a surprise announcement, the SGE said today that the international board will go-live this Thursday September 18, eleven days ahead of its original launch date of Monday September 29.
Forty members of the Exchange including global banks UBS, Goldman Sachs, HSBC and Standard Chartered, will participate in gold trading on the SGE’s international board, trading 11 yuan denominated physical gold contracts including the large 12.5 kg (400 oz) bar, the ever popular 1 kg bar and a 100 gram contract.
The location of the SGE international board in the Shanghai free trade zone is symbolic in that this location has been earmarked by the Chinese government as part of financial sector internationalisation strategy.
The SGE is also opening a precious metals vaulting facility in the free trade zone with a 1,000 tonne capacity limit.
In a related development yesterday, the Hong Kong based precious metals trade organisation, the Chinese Gold and Silver Society (CGSE) announced that they have been given permission by the Chinese government to construct a precious metals storage vaulting facility in a special economic zone in Shenzhen in China.
The CGSE is the the first non-mainland entity to be given such permission. The CGSE’s vaulting facility will have a 1,500 tonne capacity and will be completed by late 2016 or early 2017.
Developments in the Asian precious metals markets are continuing to advance at a rapid pace. The pace of developments changes daily as illustrated by the acceleration this week of the Shanghai Gold Exchange’s international board.
With the phase II trial drugs candidate, there is too much uncertain factors. Usually, investors will forget it and the stock will return its original base soon.
No, AVP-923 combines an over-the-counter cough suppressant dextromethorphan with generic quinidine (commonly used to control heartbeats.) Avanir already markets AVP-923 under the brand name Neudexta as a treatment to dull episodes of uncontrolled laughing and crying in patients with pseudobulbar affect. Insurance companies have placed significant restrictions on Neudexta reimbursements, which hampers Avanir's commercial efforts. Neudexta sales only reached $75 million last year and are on track to top $100 million this year. With today's surging stock price, Avanir's market cap approaches $2 billion.
what a stupid question! what about the price for everything else during this period?
Chinese keep buying gold.
SGE delivered over 60 tonnes of gold in last 5 trading days.
Current China only has 15 years reserve and must reduce the product capacity. RRE price will go up quickly for sure.
MCP expecta big rebound
Look like back to $4-4.5, then may stable.
I shorted last Friday At 6; 6.38; 6.7; and 6.98 ,
that was so good. and happy.
China has quote for last several years, now The quote will be removed in half year because WTO decision. However, China will close 24 rare earth factories immediately to reduce the product by 100000 tonnes annually ang also add environment tax on it, so the price will go up for sure,
China plan to cut 70% of product ability, about 80% of annual export, That is not enough?
for long term. China reduce the export of rare earth elements for sure.
HTBX jumped over 70% in 2 days for no discernible reason.
This is apparently manipulated .
It will be back to where it should be, whatever how high it run anyway.
biotech startup Achillion Pharmaceuticals (NASDAQ:ACHN) reported that its drug ACH-3102 achieved a 100% cure rate of hepatitis C patients who took it with Sovaldi for eight weeks in a phase-two study. The stock jumped 21% to a two-year high of 10.20 early Friday, though by midday it had fallen to near 9.20, up 9%.
Achillion does not have a partnership with Gilead, and Gilead is rolling out its own combo pill with a near-perfect cure rate this fall. The market response might have had more to do with Achillion's buyout prospects. Ever since Merck agreed to acquire Idenix in June, Achillion has been widely speculated to be a target for another hep C player looking to fill out its portfolio for a combo therapy, keeping its stock price elevated.
Read More At Investor's Business Daily: http://news.investors.com/technology/081514-713436-gild-stock-rises-on-sovaldi-wins.htm#ixzz3AUtLzgi5
Follow us: @IBDinvestors on Twitter | InvestorsBusinessDaily on Facebook
yonglili2000 • Jul 16, 2014 11:40
INSM is a real overvalue stock. The CAP still is over 700 millions for a company with only in phase II trial drug. it need tons of money for the clinic trial in the future. It must sell more equity or get loan for next year research.
Believe or not, there are a lot of uncertain before a long way to go the market.